A Randomized Phase II-study to Evaluate the Safety and Efficacy of Capecitabine Plus Irinotecan Plus Cetuximab Compared to Capecitabine Plus Oxaliplatin Plus Cetuximab in First-line Treatment of Patients With Metastatic Colorectal Cancer
Latest Information Update: 05 Jul 2022
At a glance
- Drugs Cetuximab (Primary) ; Capecitabine; Irinotecan; Oxaliplatin
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- Acronyms CIOX
- 07 Jun 2022 Results of pooled analysis assessing prognostic and predictive value of primary tumor location by using data from five studies (FIRE-1, CIOX, XELAVIRI, FIRE-3, and VOLFI) presented at the 58th Annual Meeting of the American Society of Clinical Oncology
- 17 Sep 2020 Results (n=688) of pooled analysis assessing biomarker analysis for AREG- and EREG mRNA expression in the FIRE-1, CIOX (FIRE-2) and FIRE-3, published in the Clinical Cancer Research.
- 31 May 2020 Results of pooled analysis from FIRE-1, CIOX and FIRE-3 presented at the 56th Annual Meeting of the American Society of Clinical Oncology